Sound Pharmaceuticals gets NIH grant for Covid-19 candidate SPI-1005
Sound Pharmaceuticals has secured a grant of $3.1 million for supporting the evaluation of its COVID-19 treatment candidate SPI-1005 in two phase 2 clinical trials from the National Center for Advancing Translational Sciences (NCATS) at the US National Institutes of Health (NIH). SPI-1005 is an oral capsule, which contains a small molecule called ebselen that […]